Meeting NewsVideo

VIDEO: Blood-based panel detects early-stage liver cancer

November 13, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Naga P. Chalasani, MD, from the Indiana University School of Medicine, discusses…

In the Journals

New treatment approaches induce responses in unresectable intrahepatic cholangiocarcinoma

November 6, 2019
Chemotherapy combined with hepatic arterial infusion of floxuridine or with selective internal radiotherapy induced antitumor activity among patients…

Namodenoson compassionate use program for HCC launches

November 4, 2019
Can-Fite BioPharma announced the initiation of a compassionate use program for Namodenoson to treat patients with hepatocellular carcinoma, according…

Meeting NewsVideo

VIDEO: National Liver Conference covers new, underused therapies for liver disease

October 31, 2019
SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Stephen A. Harrison, MD, medical director of Pinnacle Clinical…

Tecentriq, Avastin combination improves survival in unresectable HCC

October 29, 2019
Combination treatment with Tecentriq and Avastin for unresectable hepatocellular carcinoma in patients without prior systemic therapy demonstrated…

Meeting News

National Liver Conference to cover ‘tsunami’ of new data on liver disease

October 24, 2019
SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services…

Meeting NewsVideo

VIDEO: Pediatric hepatoblastoma ‘tip of the iceberg’ in predicting future disease

October 21, 2019
CHICAGO — In this exclusive video from NASPGHAN 2019, Hassan M. Abdullah, MD, from the Rainbow Babies and Children’s Hospital in…

Atezolizumab-bevacizumab combination extends survival in unresectable HCC

October 21, 2019
The combination of atezolizumab and bevacizumab prolonged survival compared with standard-of-care sorafenib for patients with unresectable…

In the Journals

HCV cure improves survival in post-DAA liver cancer development

October 16, 2019
Patients who developed hepatitis C-related hepatocellular carcinoma after achieving sustained virologic response with interferon-free direct-acting…

Meeting News

NASPGHAN 2019 chronic liver disease symposium provides update for GIs

October 16, 2019
CHICAGO — During this year’s North American Society for Pediatric Gastroenterology, Hepatology & Nutrition annual meeting, Mercedes

In the Journals

HIV/HCV vs. HCV monoinfection present similar liver cancer rates

October 15, 2019
In contrast to previous study results, hepatocellular carcinoma and decompensated cirrhosis rates were similar between patients coinfected with…

Liver cancer pipeline: 6 latest reports

October 14, 2019
As liver cancer rates continue to increase globally, researchers have focused on novel treatment options including combination therapies and…

Fotivda, Imfinzi combination trial for liver cancer begins enrollment

October 10, 2019
AVEO Oncology initiated enrollment in an early trial of a combination therapy using Fotivda and Imfinzi for the treatment of hepatocellular carcinoma…

FGFR inhibitor improves survival in previously treated cholangiocarcinoma

October 2, 2019
Incyte announced positive overall response rate and progression-free survival results for pemigatinib, a selective fibroblast growth factor receptor…

In the Journals

Statins reduce liver cancer risk in patients with chronic HBV

October 1, 2019
Statin therapy correlated with a reduced risk for hepatocellular carcinoma in patients with chronic hepatitis B, according to results published in…

Meeting NewsPerspective

HCC trial misses OS endpoint, but researchers report ‘clinically meaningful’ benefit with nivolumab

September 27, 2019
BARCELONA, Spain — Nivolumab did not significantly extend OS compared with sorafenib as first-line therapy for patients with advanced…

Meeting News

Cabometyx superior to Stivarga as second-line liver cancer treatment

September 24, 2019
Treatment with Cabometyx as second-line therapy for patients with advanced hepatocellular carcinoma who previously received Nexavar demonstrated…

Meeting News

Novel radiotherapy for liver cancer demonstrates complete, partial responses

September 20, 2019
Nanobiotix announced positive results of the NBTXR3 activated by stereotactic body radiation, or SBRT, for the treatment of hepatocellular carcinoma…

In the Journals

Several significant cholangiocarcinoma risk factors identified

September 18, 2019
Results from a systematic review and meta-analysis revealed 13 risk factors for intrahepatic and extrahepatic cholangiocarcinoma, the most…

In the Journals

MELD-GRAIL-Na score may improve liver transplant waitlist mortality prediction

September 17, 2019
Replacing serum creatinine with estimated glomerular filtration rate in a patient’s MELD-Na score appeared to improve waitlist mortality…

Healio Jobs